 |
 |

Heterogeneity in Spasmodic DysphoniaNeurologic and Voice Findings
Kenneth D. Pool, MD;
Frances J. Freeman, PhD;
Terese Finitzo, PhD;
Mari M. Hayashi, PhD;
Sandra B. Chapman, PhD;
Michael D. Devous, Sr, PhD;
Lanny G. Close, MD;
George V. Kondraske, PhD;
Dianne Mendelsohn, MD;
Steven D. Schaefer, MD;
Ben C. Watson, PhD
Arch Neurol. 1991;48(3):305-309.
Abstract
Spasmodic dysphonia is a disturbance of phonation with laryngeal spasms. We report voice and neurologic examination findings in 45 subjects. Neurologic abnormalities were found in 32 subjects (71.1%). Rapid alternating movement abnormalities, weakness, and tremor were common. Incoordination and spasticity were rare. Lower extremity findings were frequent. Abnormalities were bilateral. Spasmodic dysphonia severity was related to age. Type, severity, and duration of vocal symptoms were not different for subjects with or without neurologic abnormalities. Vocal tremor was more frequent in neurologically abnormal subjects. Involvement of a pallidothalamic—supplementary motor area system could account for neurologic findings, brain imaging findings, and clinical heterogeneity. The view emerging is that spasmodic dysphonia is a manifestation of disordered motor control involving systems of neurons rather than single anatomical sites.
Author Affiliations
From the Dallas (Tex) Center for Vocal Motor Control (Drs Pool, Freeman, Finitzo, Hayashi, Chapman, Devous, Close, Kondraske, Mendelsohn, Schaefer, and Watson); the Neuroscience Research Center (Drs Pool and Finitzo); The University of Texas at Dallas—Callier Center (Drs Freeman, Finitzo, Hayashi, Chapman, and Watson); the Departments of Radiology (Drs Devous and Mendelsohn) and Otolaryngology (Drs Close and Schaefer), The University of Texas Southwestern Medical Center at Dallas; and the Department of Biomedical Engineering, The University of Texas at Arlington (Dr Kondraske).
Footnotes
Accepted for publication August 1, 1990.
Reprints not available.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Alterations in CNS Activity Induced by Botulinum Toxin Treatment in Spasmodic Dysphonia: An H215O PET Study
Ali et al.
JSLHR 2006;49:1127-1146.
ABSTRACT
| FULL TEXT
Perceptual Analyses of Spasmodic Dysphonia Before and After Treatment
Cannito et al.
Arch Otolaryngol Head Neck Surg 2004;130:1393-1399.
ABSTRACT
| FULL TEXT
|